A Functional Observational Battery for Use in Canine Toxicity Studies: Development and Validation

International Journal of Toxicology

Volumn 22, Issue 6, 2003, Pages 415-422

  Gad, S C ^a   Gad, S E ^a  

^a Gad Consulting Services   (United States)

Author keywords

Functional Observational Battery (FOB); Neuropharmacologic Effects; Safety Pharmacology

Indexed keywords

6 AMINONICOTINAMIDE; ACRYLAMIDE; LASALOCID; MERCURY; METHANOL; METRONIDAZOLE; NEUROTOXIN; ORGANOTIN COMPOUND;

ANIMAL MODEL; ARTICLE; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOG; DRUG SAFETY; FUNCTIONAL OBSERVATIONAL BATTERY; NEUROPHARMACOLOGY; NEUROTOXICITY; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; SPECIES DIFFERENCE; TOXICITY TESTING;

ANIMALIA; CANIS FAMILIARIS; RODENTIA;

EID: 0347087363     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1177/109158180302200602     Document Type: Article

References (17)

1. Blight, A. R., J. P. Toombs, M. S. Bauer, and W. R. Widmer. 1991. The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: A phase I clinical trial. J. Neurotrauma 8:103-119.
2. Gad, S. C. 1981. A sensory/neuromuscular screen for use in industrial toxicology. Presented at SOT 1981 Meeting in San Diego, CA.
3. Gad, S. C. 1982a. A neuromuscular screen for use in industrial toxicology. J. Toxicol. Environ. Health 9:691-704.
4. Gad, S. C. 1982b. Statistical analysis of behavioral toxicology data and studies. Arch. Toxicol. Suppl. 5:256-266.
5. Gad, S. C. 1988. An approach to the design and analysis of screening studies in toxicology. J. Am. Coll. Toxicol. 7:127-138.
6. Gad, S. C. 1989. Screens in neurotoxicology: Objectives, design and analysis, with the functional observational battery as an example. J. Am. Coll. Toxicol. 8:287-301.
7. Haggerty, G. C. 1991. Strategy for and experiences with neurotoxicity testing of new pharmaceuticals. J. Am. Coll. Toxicol. 10:677-688.
8. Jaggy, A., J. E. Olenen, D. C. Ferguson, E. A. Mahaffey, and T. Glaus. 1994. Neurologic manifestation of hypothyrodism: A retrospective study of 29 dogs. J. Vet. Intern. Med. 8:328-336.
9. Jones, R. D., T. F. Hastings, and A. M. Landers. 1999. Absence of neurovisual effects due to tissue and blood cholinesterase depression in a chronic disalfoton feeding study in dogs. Toxicol. Literature 106:181-190.
10. Krinke, G. J., and W. Classen. 1998. Spongiform neuropathy induced in dogs by prolonged low-level administration of 6-aminonicotinamide (6-ANA). Exp. Toxicol. Pathol. 50:277-282.
11. O'Brien, D. 1994. Neurological evaluation and development of the neonatal dog. Semin. Vet. Med. Surg. (Small Anim.) 2:62-67.
12. Oheda, R., T. Karahama, T. Kimura, S. Toizumi, T. Mitsushimi, and T. Yohozama. 1984. Neuropathologic study on chronic neurotoxicity of 5-flurouracil and its masked compounds in dogs. Acta Neuropathol. 63:333-343.
13. Oliver, J. E., and M. D. Lorenz. 1993. Handbook of veterinary neurology, 2nd ed. Philadelphia: W. B. Saunders.
14. Schaeppi, U., and G. Krimbe. 1982. Pyridomine neuropathy: Correlation of functional tests and neuropathology in beagle dog treated with large doses of vitamin B6. Agents Actions 12:575-582.
15. Sogabe, K., H. Hashimoto, and M. Nakashima. 1985. Affinities of adrenergic drugs for alpha 2-adrenoceptors in dog saphenous vein in comparison with those in rat brain or human platelets. Blood Vessels 22:127-138.
16. Spencer, C. P., C. L. Chrissman, I. G. Mayhew, and J. V. Klaude. 1982. Neurotoxicologic effects of the nonionic contrast agent iopamidol on the leptomenenges of the dog. Am. J. Vet. Res. 43:1958-1962.
17. Tilson, H. A., and V. C. Moser. 1992. Comparison of screening approaches. Neuro Toxicol. 13:1-14.